Navigation Links
Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
Date:4/25/2012

THOUSAND OAKS, Calif. and ISTANBUL, April 25, 2012 /PRNewswire/ -- Amgen (NASDAQ: AMGN), the world's largest biotechnology company, and Mustafa Nevzat Pharmaceuticals (MN) today announced an agreement under which Amgen will acquire 95.6 percent of shares in MN, a privately held Turkish pharmaceutical company, for an amount that values MN at US $700 million. The all-cash transaction will significantly expand Amgen's presence in Turkey and the surrounding region, which are large, fast-growing, priority markets for Amgen.

"Amgen is dedicated to making our innovative medicines available to patients in major markets around the world," said Robert A. Bradway, president and chief operating officer at Amgen.  "Together with MN's staff and management team, we plan to grow our business with high quality and innovative medicines in Turkey and the surrounding region."

With a heritage of nearly 90 years, MN is the leading supplier of pharmaceuticals to the hospital sector and a major supplier of injectable medicines in Turkey. It also has a successful and fast growing export business. MN had revenues of approximately US $200 million in 2011 and has grown on average at double-digit rates in local currency over the past five years.

"This transaction represents an attractive opportunity for MN, its employees and customers," said Levent Selamoglu, general manager and chief executive officer of MN. "The combination of MN and Amgen creates an innovation leader in Turkey with unique capabilities and scope to expand regionally and in other attractive high-growth markets.  Amgen's focus and resources will also ensure continued investment in Turkey."

The transaction has been approved by the Board of Directors of each company. Completion of the transaction is subject to customary closing conditions, including regulatory approvals. 

Amgen's focus on Turk
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Amgen Announces Webcast of 2012 First Quarter Financial Results
2. UCB and Amgen Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis
3. Amgen Completes Tender Offer for Outstanding Shares of Micromet, Inc.
4. Schwartz Center Receives $500,000 Grant from the Amgen Foundation
5. Amgen to Present at the Cowen and Company 32nd Annual Healthcare Conference
6. Amgen and Micromet Announce Early Termination of HSR Waiting Period for Amgens Acquisition of Micromet
7. Amgens Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33
8. Amgen Announces Final Results of Its Tender Offer
9. Amgen Announces Preliminary Results of Its Tender Offer
10. AMG 277 Discriminates Against S1P3 Receptor by 50-fold. S1P1 Lead Compounds Will Be Offered for Sale at a December 8, 2011 Sealed Bid Sale. Assets Generated by Epix Pharmaceuticals, Inc. and Amgen.
11. Amgen Statement on European Investor Visit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 2015 Research and Markets( http://www.researchandmarkets.com/research/28m7nx/guide_to_prepare ) ... to Prepare Application Dossiers for Oversea Medical device ... report to their offering. The ... market of the most growth potentiality, which is ... and producers to penetrate such market. It is ...
(Date:5/22/2015)... 22, 2015 Research and Markets ... the "Latest Regulations on Pharmaceutical International Multi-Center ... offering. This is first time in ... on international multi-center clinical trials of drugs in ... to be implemented on March 1, 2015. The ...
(Date:5/22/2015)... a sweeping analysis assessing the current state of diabetes ... conclude that there remains considerable room for improving treatment ... but especially for adolescents and young adults. The analysis ... the need to address barriers to care and implement ... patients achieve optimal metabolic control. The ...
Breaking Medicine Technology:China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 2China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 32015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 2Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 3Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 5
... , WAYNE, N.J., Nov. 24 MAQUET Cardiovascular ... that it has signed a guaranteed two-year contract with ... to be the sole source provider of surgical devices ... of the agreement, which runs through October 31, 2012, ...
... , , MOUNTAIN VIEW, Calif., ... and leading providers of kidney dialysis services and a major ... Renal Disease survivor and chef Elias Nasrallah in his effort ... Elias Nasrallah built a successful career as a chef for ...
Cached Medicine Technology:MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 3Satellite Healthcare and Renal Disease Survivor Elias Nasrallah Join Forces to Support the Homeless This Holiday Season 2
(Date:5/22/2015)... Combination therapy, or polytherapy, will ... obstructive pulmonary disorder (COPD) as the dominant companies ... as well as Germany’s Boehringer Ingelheim compete with ... will market payers, clinicians and patients be disposed ... completely new ones? , In spite of recently ...
(Date:5/22/2015)... 22, 2015 Coordinating care for ... process. Historically providers have not been reimbursed or ... in 2015, Medicare has paved the way by ... to the launch of Oculus Health , ... systems using the platform will now be able ...
(Date:5/22/2015)... ZH Healthcare (ZH), a ... that Bill Lane, joins ZH’s Advisory Board. ... first of its kind, Freemium SaaS, Electronic Health ... Records (EHR) with an integrated practice management system ... portal, and more. Combined with its Revenue Cycle ...
(Date:5/22/2015)... 22, 2015 sweetFrog Enterprises, LLC. is pleased ... Texas. Jacksonville is now the 16th sweetFrog store located in ... listed as #22 on the Inc. 500 list of fastest ... and worked in East Texas for 20 years and love ... of the Jacksonville, and nearby Palestine, sweetFrog locations. “We are ...
(Date:5/22/2015)... AZ (PRWEB) May 22, 2015 In ... Olympics, Parker and Sons is offering to donate $5 ... installing an AC unit or water softening system. Customers ... behalf; Parker and Sons gets business; and the Special ... , The Special Olympics helps over 4.4 million athletes, ...
Breaking Medicine News(10 mins):Health News:Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com 2Health News:Oculus Health Care Coordination Platform Officially Launched 2Health News:Oculus Health Care Coordination Platform Officially Launched 3Health News:Oculus Health Care Coordination Platform Officially Launched 4Health News:ZH Healthcare Adds Bill Lane to Advisory Board 2Health News:sweetFrog Opens New Location in Jacksonville, Texas 2Health News:Parker and Sons is Proud to Support the Special Olympics with Their Everybody Wins Program 2
... at-risk patient groups , FRIDAY, Dec. 4 (HealthDay News) ... nervous system tumors, carry the risk of late recurrence, ... data from 12,795 five-year survivors of the most common ... Survivor Study. , The researchers found that the overall ...
... inhaled through hookah, research shows , FRIDAY, Dec. 4 (HealthDay ... smoking tobacco, researchers say. , A new study found that ... monoxide and nicotine, which puts them at risk for heart ... aged 18 to 50, who smoked tobacco using a water ...
... ... ... garnering national attention with an invention proven to help individuals lose weight, prevent disease, ... Technology Fair located at the Civic Center Gallery., , , , , TrekDesk ...
... , BOULDER, ... TEACHER, ON LOVE , Kathryn Budig, a prominent yoga teacher, ... viewing of Twilight,s New Moon along the way. , To ... KING AND BREAST CANCER , elephantjournal.com takes a ...
... N.J., Dec. 4 Movado Group Inc. (NYSE: ... Georgia, shared in a tribute on December 3, 2009, to ... performance in the tournament. Melanie became the youngest American quarterfinalist ... http://www.newscom.com/cgi-bin/prnh/20091204/NY21184 ) , At a celebratory reception held at Brown ...
... , PACIFIC PALISADES, Calif., Dec. 4 Forget the ... something they can be proud of - beautiful, younger-appearing ... and men will love the ultimate youthful appearance made ... and neck combined. , Dermagenics Ultra-Intensive Anti-Wrinkle Beauty Moisturizer ...
Cached Medicine News:Health News:Water Pipes No Safer Than Cigarettes 2Health News:Valley Health Invention Making National Splash Showcased at Scottsdale Civic Center Gallery 2Health News:Give the Gift of Beautiful Skin for the Holiday Season 2
Inquire...
The essence of fluorescence analysis is sensitivity. The high throughput optical system in the RF-5301PC employs a blazed holographic grating, photomultiplier and digital signal processing to provide...
The Fluoroskan Ascent, a dedicated microplate fluorometer, offers high sensitivity for a wide variety of fluorometric applications....
... 200 is a fixed wavelength fluorometer ... nm emission. The spectral characteristics are ... double-stranded DNA using the standard Hoechst ... interference from the presence of protein, ...
Medicine Products: